Skip to main content

Table 3 Histopathological results of 336 eligible patients

From: The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study

 

Preop. CRT (n = 177)

Postop. CRT (n = 159)

p value

R classification—n (%)

  

0.172

 R0

163 (92.1)

139 (87.4)

 *R1

14 (7.9)

20 (12.6)

pT category—n (%)

  

p < 0.001

 T0

24 (13.5)

 T1

10 (5.5)

2 (1.3)

 T2

36 (20.0)

6 (3.8)

 T3

92 (52.0)

133 (83.6)

 T4a

8 (4.5)

16 (9.6)

 T4b

8 (4.5)

2 (1.3)

pN category—n (%)

  

p < 0.001

 N0

120 (67.8)

80 (50.3)

 N1a

25 (14.1)

25 (15.7)

 N1b

15 (8.5)

26 (16.4)

 N1c

3 (1.7)

2 (1.3)

 N2a

11 (6.2)

10 (6.3)

 N2b

3 (1.7)

16 (10.1)

Stage—n (%)

  

p < 0.001

 **Grade 0/PCR

23 (13.0)

 Grade 1

36 (20.0)

 Grade 2a

50 (28.2)

74 (46.5)

  2b

7 (4.1)

4 (2.5)

  2c

4 (2.3)

2 (1.3)

 Grade 3a

11 (6.3)

8 (5.0)

  3b

39 (22.0)

53 (33.3)

  3c

7 (4.1)

18 (11.3)

Differentiation—n (%)

  

0.091

 Well differentiation

15 (8.4)

16 (10.1)

 Moderate differentiation

146 (82.5)

114 (71.7)

 Poor differentiation—signed ring cell

7 (4.0)

14 (8.8)

 Mucineous

9 (5.1)

15 (9.4)

+ PNI—n (%)

  

0.008

 Present

10 (5.5)

23 (14.5)

p < 0.001

++ LVI—n (%)

  

 Present

3 (1.7)

20 (12.6)

  1. + PNI perineural invasion, ++ LVI lenfovascular invasion
  2. *Circumferential resection margin ≤ 1 mm or distal resection margin ≤ 1 cm distance from tumor defined as R1 resection
  3. **Pathologic complete response